ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 130 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $24,802,000 | +242.1% | 4,113,556 | +104.3% | 0.00% | +50.0% |
| Q3 2019 | $7,249,000 | +45.4% | 2,013,693 | +8.3% | 0.00% | +100.0% |
| Q2 2019 | $4,985,000 | -3.7% | 1,860,151 | +6.4% | 0.00% | 0.0% |
| Q1 2019 | $5,174,000 | +5.2% | 1,748,069 | -43.5% | 0.00% | 0.0% |
| Q4 2018 | $4,918,000 | -8.2% | 3,094,008 | +112.6% | 0.00% | -50.0% |
| Q3 2018 | $5,356,000 | +31.7% | 1,455,658 | +1.2% | 0.00% | +100.0% |
| Q2 2018 | $4,068,000 | -15.3% | 1,437,697 | +11.1% | 0.00% | -50.0% |
| Q1 2018 | $4,802,000 | +58.2% | 1,294,347 | +22.8% | 0.00% | +100.0% |
| Q4 2017 | $3,035,000 | -35.2% | 1,053,860 | +1.1% | 0.00% | -50.0% |
| Q3 2017 | $4,682,000 | -4.9% | 1,042,866 | -2.8% | 0.00% | 0.0% |
| Q2 2017 | $4,925,000 | +16.7% | 1,073,029 | +7.0% | 0.00% | 0.0% |
| Q1 2017 | $4,221,000 | +12.2% | 1,002,784 | +10.1% | 0.00% | 0.0% |
| Q4 2016 | $3,761,000 | -52.2% | 910,741 | -6.3% | 0.00% | -50.0% |
| Q3 2016 | $7,875,000 | +14.7% | 972,231 | +10.4% | 0.00% | 0.0% |
| Q2 2016 | $6,865,000 | +11.5% | 880,254 | +10.4% | 0.00% | +33.3% |
| Q1 2016 | $6,156,000 | -25.7% | 797,518 | +3.9% | 0.00% | -40.0% |
| Q4 2015 | $8,281,000 | +66.2% | 767,495 | +6.4% | 0.01% | +66.7% |
| Q3 2015 | $4,984,000 | -18.3% | 721,274 | +4.7% | 0.00% | 0.0% |
| Q2 2015 | $6,100,000 | -5.5% | 688,632 | +5.2% | 0.00% | -25.0% |
| Q1 2015 | $6,452,000 | -5.0% | 654,385 | +18.0% | 0.00% | 0.0% |
| Q4 2014 | $6,791,000 | +27.6% | 554,419 | +3.9% | 0.00% | +33.3% |
| Q3 2014 | $5,324,000 | +39.9% | 533,532 | +6.1% | 0.00% | +50.0% |
| Q2 2014 | $3,806,000 | +157.2% | 502,892 | +11.7% | 0.00% | +100.0% |
| Q1 2014 | $1,480,000 | +8.9% | 450,043 | +9.9% | 0.00% | 0.0% |
| Q4 2013 | $1,359,000 | +12.7% | 409,495 | +2.5% | 0.00% | 0.0% |
| Q3 2013 | $1,206,000 | -53.7% | 399,478 | +25.4% | 0.00% | -50.0% |
| Q2 2013 | $2,605,000 | – | 318,453 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 5,191,600 | $8,255,000 | 4.47% |
| RTW INVESTMENTS, LP | 13,749,383 | $21,862,000 | 2.04% |
| ARMISTICE CAPITAL, LLC | 4,300,000 | $6,837,000 | 0.52% |
| DAFNA Capital Management LLC | 630,182 | $1,002,000 | 0.50% |
| Rock Springs Capital Management LP | 2,325,000 | $3,697,000 | 0.18% |
| 683 Capital Management, LLC | 1,000,000 | $1,590,000 | 0.10% |
| Alambic Investment Management, L.P. | 133,698 | $213,000 | 0.09% |
| South Dakota Investment Council | 3,037,004 | $7,310,000 | 0.08% |
| Alpine Global Management, LLC | 205,172 | $326,000 | 0.08% |
| Rhenman & Partners Asset Management AB | 402,800 | $640,000 | 0.07% |